Reimbursement Intelligence Announces a Series of Major Key Strategic and Organization Changes
January 15, 2014 08:14 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwired - Jan 15, 2014) - Reimbursement Intelligence (RI), an information and marketing services firm that provides expert insights and solutions about the changing healthcare...
Reimbursement Intelligence: Payers Struggling to Manage Combination Use of Costly Prostate Cancer Therapies
November 09, 2012 09:48 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - Nov 9, 2012) - Forty-seven percent of US payers surveyed indicate they plan to tightly manage the use of combination therapies to treat prostate cancer, according to data...
Reimbursement Intelligence: Tofacitinib to Be Positioned After Anti-TNFs, Say Payers Based on FDA Panel Review
May 15, 2012 10:48 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - May 15, 2012) - Reimbursement Intelligence (RI), the New Jersey-based market research firm helping biopharma, medical device and diagnostics firms succeed in the managed...
Cancer Drug Costs Unsustainable, According to Value & Innovation Webinar
March 30, 2012 11:32 ET
|
Value & Innovation
WESTPORT, CT--(Marketwire - Mar 30, 2012) - The current economic model for treating cancer is badly broken, according to senior executives from healthcare insurance companies who discussed the...
Reimbursement Intelligence: Oral Small Molecules for RA Face High Price-Sensitivity Hurdles
March 20, 2012 13:35 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - Mar 20, 2012) - Reimbursement Intelligence, the New Jersey-based market research firm helping biopharma, medical device and diagnostics firms succeed in managed markets,...
Payers Say Birth Control Mandate Will Increase Premiums According to Reimbursement Intelligence
February 17, 2012 10:46 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - Feb 17, 2012) - Reimbursement Intelligence (RI), the New Jersey-based market research firm that specializes in reimbursement-related issues for medical and pharmaceutical...
Payers Outlook for Lipitor Generic Strategy Not Rosy: Market Share Decline Coming Soon
December 02, 2011 10:19 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - Dec 2, 2011) - Reimbursement Intelligence, the New Jersey-based market-research firm helping biopharma, medical device and diagnostic firms succeed in managed markets,...
Payers to Pharma: In Rheumatology, Innovations Without Outcomes Are Irrelevant
November 30, 2011 11:06 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - Nov 30, 2011) - Reimbursement Intelligence, a New Jersey-based market-research firm, today announced at the 2011 American College of Rheumatology dinner presentation...
Real Endpoints Launches New Reimbursement-Focused Information Service
November 29, 2011 10:07 ET
|
Real Endpoints
WESTPORT, CT--(Marketwire - Nov 29, 2011) - Real Endpoints LLC, a new information company focused on healthcare reimbursement, announced today the launch of its Value & Innovation LLC...
Reimbursement Intelligence Brings On New Chief Commercial Officer
November 17, 2011 10:06 ET
|
Reimbursement Intelligence
MADISON, NJ--(Marketwire - Nov 17, 2011) - Reimbursement Intelligence, the New Jersey-based market-research firm helping biopharma, medical device and diagnostic firms succeed in managed markets,...